SCHEMBL22774580

SCHEMBL22774580

Cn1cc(C=O)c(=O)c2cc(F)c(Cl)cc21

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 4/20 0.47
▸ KDM4E B2RXH2 1/20 0.47
▸ GSK3B P49841 5/20 0.41
▸ IMPDH2 P12268 1/20 0.41
▸ PIM1 P11309 5/20 0.39
▸ PIM2 Q9P1W9 3/20 0.39
▸ GSK3A P49840 1/20 0.39
▸ PIM3 Q86V86 1/20 0.39
▸ CDK1 P06493 2/20 0.38
▸ CDK4 P11802 2/20 0.38
▸ CCNB1 P14635 2/20 0.38
▸ CCND1 P24385 2/20 0.38
▸ CDK2 P24941 2/20 0.38
▸ CDK5 Q00535 2/20 0.38
▸ CDK5R1 Q15078 2/20 0.38
▸ CCNT1 O60563 1/20 0.38
▸ CCND3 P30281 1/20 0.38
▸ CDK9 P50750 1/20 0.38
▸ CDK3 Q00526 1/20 0.38
▸ CDK6 Q00534 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29577008 1.00 ALDH1A1 (0.47) ALDH1A1KDM4EGSK3BIMPDH2PIM1
SCHEMBL22774058 0.78 ALDH1A1 (0.40) ALDH1A1KDM4EPIM1PIM2GSK3A
SCHEMBL29576915 0.78 ALDH1A1 (0.40) ALDH1A1KDM4EPIM1PIM2GSK3A
SCHEMBL29577405 0.75 LMNA (0.49) ALDH1A1KDM4EGSK3BPIM1LMNA
SCHEMBL6669710 0.75 LMNA (0.49) ALDH1A1KDM4EGSK3BPIM1LMNA
SCHEMBL10627377 0.75 TP53 (0.50) GSK3BLMNATHRBTP53RXFP1
SCHEMBL10626314 0.72 TP53 (0.47) GSK3BLMNATHRBTP53RXFP1
SCHEMBL10627386 0.72 TP53 (0.47) GSK3BLMNATHRBTP53RXFP1
SCHEMBL10618840 0.70 ALDH1A1 (0.46) ALDH1A1GSK3BPIM1PIM2GSK3A
SCHEMBL10874926 0.70 GSK3B (0.43) KDM4EGSK3BPIM1PIM2GSK3A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250313561-A1 NEXT-GENERATION MODULATORS OF STIMULATOR OF INTERFERON GENES (STING) RYVU THERAPEUTICS S A (PL) 2025-10-09 — — US disclosed
US-12344606-B2 Next-generation modulators of stimulator of interferon genes (STING) Ryvu Therapeutics S.A. (PL) 2025-07-01 — — US disclosed
EP-3983078-B1 NEXT-GENERATION MODULATORS OF STIMULATOR OF INTERFERON GENES (STING) RYVU THERAPEUTICS S A (PL) 2023-11-15 — — EP disclosed
US-20220251082-A1 NEXT-GENERATION MODULATORS OF STIMULATOR OF INTERFERON GENES (STING) Ryvu Therapeutics S.A. (PL) 2022-08-11 — — US disclosed
EP-3983078-A1 NEXT-GENERATION MODULATORS OF STIMULATOR OF INTERFERON GENES (STING) Ryvu Therapeutics S.A. (PL) 2022-04-20 — — EP disclosed
CN-113950473-A Next generation modulators of interferon gene Stimulators (STING) 雷沃医疗有限公司 2022-01-18 — — CN disclosed
WO-2020249773-A1 NEXT-GENERATION MODULATORS OF STIMULATOR OF INTERFERON GENES (STING) Ryvu Therapeutics S.A. (PL) 2020-12-17 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220251082-A1 NEXT-GENERATION MODULATORS OF STIMULATOR OF INTERFERON GENES (STING) STING1, IRF3, CGAS ALDH1A1 4562/4885KDM4E 4160/4885GSK3B 529/4885
US-12344606-B2 Next-generation modulators of stimulator of interferon genes (STING) STING1, IRF3, CGAS ALDH1A1 4562/4885KDM4E 4160/4885GSK3B 529/4885
US-20250313561-A1 NEXT-GENERATION MODULATORS OF STIMULATOR OF INTERFERON GENES (STING) STING1, IRF3, CGAS ALDH1A1 4562/4885KDM4E 4160/4885GSK3B 529/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback